Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	actin filament binding	MYH10 ABL2 MYO1E MYO7B GAS7 VPS16 SVIL MACF1 PLEC	2.45e-05	227	135	9	GO:0051015
GeneOntologyMolecularFunction	actin binding	MYH10 ABL2 MYO1E MYO7B COBLL1 LRRK2 GAS7 VPS16 SVIL ENAH MACF1 PLEC	1.02e-04	479	135	12	GO:0003779
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH10 DNAH10 MYO1E MYO7B DNAH9 DNAH11	1.51e-04	118	135	6	GO:0003774
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	KALRN SLC38A9 DOCK10 ARFGEF2 ARHGEF10L RIN2 ARHGEF9 RIC1	1.78e-04	231	135	8	GO:0005085
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH10 DNAH9 DNAH11	2.29e-04	18	135	3	GO:0008569
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	CCT3 DNAH10 KRT35 ARFGEF2 GAS7 HAUS3 VPS16 RADIL SVIL CDK5RAP2 MACF1 PLEC DNAH9 KRT36 MX1 CSTPP1 DNAH11	6.33e-05	899	134	17	GO:0099513
GeneOntologyCellularComponent	microtubule	CCT3 DNAH10 ARFGEF2 HAUS3 RADIL SVIL CDK5RAP2 MACF1 DNAH9 MX1 CSTPP1 DNAH11	1.68e-04	533	134	12	GO:0005874
GeneOntologyCellularComponent	supramolecular fiber	MYH10 CCT3 DNAH10 KRT35 ARFGEF2 GAS7 HAUS3 VPS16 RYR3 RADIL SVIL CDK5RAP2 MACF1 PLEC DNAH9 KRT36 MX1 CSTPP1 DNAH11	1.89e-04	1179	134	19	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	MYH10 CCT3 DNAH10 KRT35 ARFGEF2 GAS7 HAUS3 VPS16 RYR3 RADIL SVIL CDK5RAP2 MACF1 PLEC DNAH9 KRT36 MX1 CSTPP1 DNAH11	2.06e-04	1187	134	19	GO:0099081
GeneOntologyCellularComponent	dynein complex	DNAH10 DYNC2I1 DNAH9 DNAH11	3.98e-04	54	134	4	GO:0030286
MousePheno	decreased effector memory CD4-positive, alpha-beta T cell number	PTPRC NEK8 PRKDC	4.49e-05	10	103	3	MP:0010845
MousePheno	impaired coordination	VIPR1 MYH10 ANKFY1 ABL2 KALRN CCR9 NPAS3 GAS7 ITPR1 RAB18 VPS35 CHD6 MUSK	4.80e-05	478	103	13	MP:0001405
Domain	DHC_N1	DNAH10 DNAH9 DNAH11	1.84e-05	8	131	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH10 DNAH9 DNAH11	1.84e-05	8	131	3	IPR013594
Domain	ARM-type_fold	LRRK2 ARFGEF2 RYR3 ITPR1 FOCAD PIK3CB PI4KA VPS35 MROH7 PRKDC UNC79	2.73e-05	339	131	11	IPR016024
Domain	SPEC	AKAP6 KALRN MACF1 PLEC	7.14e-05	32	131	4	SM00150
Domain	Spectrin/alpha-actinin	AKAP6 KALRN MACF1 PLEC	7.14e-05	32	131	4	IPR018159
Domain	Kinase-like_dom	ABL2 BMP2K KALRN LRRK2 TEX14 STK32A PTK2B PIK3CB PI4KA NEK8 MACF1 PRKDC MUSK	1.15e-04	542	131	13	IPR011009
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	IPR013602
Domain	DHC_N2	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	IPR011704
Domain	MT	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	PF12777
Domain	AAA_8	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	PF12780
Domain	AAA_5	DNAH10 DNAH9 DNAH11	1.16e-04	14	131	3	PF07728
Domain	DHC_fam	DNAH10 DNAH9 DNAH11	1.44e-04	15	131	3	IPR026983
Domain	Dynein_heavy	DNAH10 DNAH9 DNAH11	1.44e-04	15	131	3	PF03028
Domain	PI3/4_kinase_CS	PIK3CB PI4KA PRKDC	1.44e-04	15	131	3	IPR018936
Domain	Dynein_heavy_dom	DNAH10 DNAH9 DNAH11	1.44e-04	15	131	3	IPR004273
Domain	-	PIK3CB PI4KA PRKDC	1.77e-04	16	131	3	1.10.1070.11
Domain	PI3Kc	PIK3CB PI4KA PRKDC	1.77e-04	16	131	3	SM00146
Domain	PI3_PI4_kinase	PIK3CB PI4KA PRKDC	2.55e-04	18	131	3	PF00454
Domain	PI3_4_KINASE_1	PIK3CB PI4KA PRKDC	2.55e-04	18	131	3	PS00915
Domain	PI3_4_KINASE_2	PIK3CB PI4KA PRKDC	2.55e-04	18	131	3	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3CB PI4KA PRKDC	2.55e-04	18	131	3	IPR000403
Domain	PI3_4_KINASE_3	PIK3CB PI4KA PRKDC	2.55e-04	18	131	3	PS50290
Domain	BRK	CHD8 CHD6	7.19e-04	6	131	2	SM00592
Domain	RIH_assoc-dom	RYR3 ITPR1	7.19e-04	6	131	2	IPR013662
Domain	-	MACF1 PLEC	7.19e-04	6	131	2	3.90.1290.10
Domain	BRK_domain	CHD8 CHD6	7.19e-04	6	131	2	IPR006576
Domain	Ins145_P3_rec	RYR3 ITPR1	7.19e-04	6	131	2	PF08709
Domain	RIH_assoc	RYR3 ITPR1	7.19e-04	6	131	2	PF08454
Domain	RIH_dom	RYR3 ITPR1	7.19e-04	6	131	2	IPR000699
Domain	Ins145_P3_rcpt	RYR3 ITPR1	7.19e-04	6	131	2	IPR014821
Domain	Ryanodine_recept-rel	RYR3 ITPR1	7.19e-04	6	131	2	IPR015925
Domain	-	RYR3 ITPR1	7.19e-04	6	131	2	1.25.10.30
Domain	RYDR_ITPR	RYR3 ITPR1	7.19e-04	6	131	2	PF01365
Domain	BRK	CHD8 CHD6	7.19e-04	6	131	2	PF07533
Domain	SH3	ABL2 MYO1E KALRN MYO7B GAS7 ARHGEF9 MACF1	8.35e-04	216	131	7	PS50002
Domain	SH3_domain	ABL2 MYO1E KALRN MYO7B GAS7 ARHGEF9 MACF1	9.29e-04	220	131	7	IPR001452
Domain	Plectin	MACF1 PLEC	1.00e-03	7	131	2	PF00681
Domain	Plectin_repeat	MACF1 PLEC	1.00e-03	7	131	2	IPR001101
Domain	PLEC	MACF1 PLEC	1.00e-03	7	131	2	SM00250
Domain	Spectrin_repeat	KALRN MACF1 PLEC	1.08e-03	29	131	3	IPR002017
Domain	Cyclin_L/T	CCNL2 CCNL1	1.33e-03	8	131	2	IPR015429
Domain	PI3Ka	PIK3CB PI4KA	1.70e-03	9	131	2	PF00613
Domain	PI3Ka	PIK3CB PI4KA	1.70e-03	9	131	2	SM00145
Domain	-	PIK3CB PI4KA	1.70e-03	9	131	2	1.25.40.70
Domain	Ubiquitin-rel_dom	MYO7B FRMD1 PTK2B RADIL PIK3CB RIN2	1.91e-03	184	131	6	IPR029071
Domain	MIR	RYR3 ITPR1	2.12e-03	10	131	2	PF02815
Domain	MIR_motif	RYR3 ITPR1	2.12e-03	10	131	2	IPR016093
Domain	PI_Kinase	PIK3CB PI4KA	2.12e-03	10	131	2	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3CB PI4KA	2.12e-03	10	131	2	IPR001263
Domain	MIR	RYR3 ITPR1	2.12e-03	10	131	2	PS50919
Domain	MIR	RYR3 ITPR1	2.12e-03	10	131	2	SM00472
Domain	PIK_HELICAL	PIK3CB PI4KA	2.12e-03	10	131	2	PS51545
Domain	Myosin_head_motor_dom	MYH10 MYO1E MYO7B	2.38e-03	38	131	3	IPR001609
Domain	MYOSIN_MOTOR	MYH10 MYO1E MYO7B	2.38e-03	38	131	3	PS51456
Domain	Myosin_head	MYH10 MYO1E MYO7B	2.38e-03	38	131	3	PF00063
Domain	MYSc	MYH10 MYO1E MYO7B	2.38e-03	38	131	3	SM00242
Domain	Ser-Thr/Tyr_kinase_cat_dom	ABL2 TEX14 PTK2B NEK8 MUSK	2.90e-03	138	131	5	IPR001245
Domain	PH_dom-like	KALRN MYO7B DOCK10 FRMD1 ARHGEF10L PTK2B ENAH ARHGEF9 ACAP2	3.14e-03	426	131	9	IPR011993
Domain	KRAB	ZNF586 ZFP57 ZNF557 ZNF792 ZNF587 ZNF641 ZNF558 ZNF417	3.78e-03	358	131	8	PS50805
Domain	KRAB	ZNF586 ZFP57 ZNF557 ZNF792 ZNF587 ZNF641 ZNF558 ZNF417	3.78e-03	358	131	8	PF01352
Domain	FERM_M	MYO7B FRMD1 PTK2B	4.11e-03	46	131	3	PF00373
Domain	SH3	ABL2 MYO1E KALRN MYO7B GAS7 ARHGEF9	4.21e-03	216	131	6	SM00326
Domain	KRAB	ZNF586 ZFP57 ZNF557 ZNF792 ZNF587 ZNF641 ZNF558 ZNF417	4.53e-03	369	131	8	SM00349
Domain	KRAB	ZNF586 ZFP57 ZNF557 ZNF792 ZNF587 ZNF641 ZNF558 ZNF417	4.61e-03	370	131	8	IPR001909
Domain	-	MYO7B FRMD1 PTK2B	4.91e-03	49	131	3	1.20.80.10
Domain	FERM_central	MYO7B FRMD1 PTK2B	4.91e-03	49	131	3	IPR019748
Domain	FERM_domain	MYO7B FRMD1 PTK2B	4.91e-03	49	131	3	IPR000299
Domain	FERM/acyl-CoA-bd_prot_3-hlx	MYO7B FRMD1 PTK2B	5.20e-03	50	131	3	IPR014352
Domain	FERM_1	MYO7B FRMD1 PTK2B	5.20e-03	50	131	3	PS00660
Domain	FERM_2	MYO7B FRMD1 PTK2B	5.20e-03	50	131	3	PS00661
Domain	FERM_3	MYO7B FRMD1 PTK2B	5.20e-03	50	131	3	PS50057
Domain	Band_41_domain	MYO7B FRMD1 PTK2B	5.20e-03	50	131	3	IPR019749
Domain	B41	MYO7B FRMD1 PTK2B	5.20e-03	50	131	3	SM00295
Domain	Cyclin_C-dom	CCNL2 CCNL1	6.20e-03	17	131	2	IPR004367
Domain	Cyclin_C	CCNL2 CCNL1	6.20e-03	17	131	2	PF02984
Domain	Cyclin_C	CCNL2 CCNL1	6.20e-03	17	131	2	SM01332
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	AKAP6 PRUNE2 ANKFY1 DOCK10 CHD8 BIRC6 UBR5 MACF1 CHD6 KLHL8	2.36e-08	225	137	10	12168954
Pubmed	A human MAP kinase interactome.	MYH10 ABL2 CCT3 COBLL1 GAS7 CHD8 EXTL3 ARHGEF9 MACF1 CHD6 PRKDC PLEC PIBF1	7.33e-08	486	137	13	20936779
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYH10 ANKFY1 NAA15 NUP107 CCT3 GNE DOCK10 CHD8 VPS16 BIRC6 TOE1 NUP205 UBR5 PI4KA VPS35 MACF1 PRKDC PLEC RPL5 PCID2	3.74e-07	1353	137	20	29467282
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH10 NUP107 CCT3 ARFGEF2 PI4KA MROH7 PRKDC PLEC	1.48e-06	202	137	8	33005030
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYO1E KALRN HECTD4 ARFGEF2 CHD8 EXTL3 BIRC6 C8orf58 ARHGEF10L FOCAD RADIL PI4KA NEK8 PRKDC PLEC RIC1 BAHCC1	1.78e-06	1105	137	17	35748872
Pubmed	A cohesin-RAD21 interactome.	CUL4A AMPD3 NAA15 CCT3 FOCAD UBE2O PRKDC RPL5	1.85e-06	208	137	8	22145905
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	AMPD3 COBLL1 GPAM MACF1 PLEC KLHL8 DNAH11	1.94e-06	146	137	7	20686565
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYH10 NAA15 NUP107 CCT3 CHD8 BIRC6 NUP205 UBE2O UBR5 MACF1 PRKDC PLEC RPL5	2.04e-06	653	137	13	22586326
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	CUL4A ITGA11 MYH10 CCT3 KRT35 CCR9 ARFGEF2 NUP205 PI4KA NEK8 PRKDC PLEC	2.61e-06	564	137	12	21565611
Pubmed	Functional proteomics mapping of a human signaling pathway.	MYH10 OTUB1 ARFGEF2 RFX1 ZNF557 PTPRC UBR5 ZNF587 VPS35 MACF1 CHD6 PLEC	4.20e-06	591	137	12	15231748
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	MYH10 NUP107 CCT3 MYO1E GNE OTUB1 VPS16 VPS35 MACF1 PRKDC PLEC RPL5	4.98e-06	601	137	12	33658012
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MXRA5 CCT3 GPAM PIWIL2 BIRC6 NUP205 FOCAD TMCO4 PI4KA PKHD1 SNX31 CHD6 PRKDC	7.42e-06	736	137	13	29676528
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	MYH10 ABL2 BMP2K JADE3 DYNC2I1 HAUS3 CCDC77 NUP205 UBR5 SVIL ENAH PLEC PIBF1 PCID2	7.49e-06	853	137	14	28718761
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	ANKFY1 NAA15 NUP107 GNE CHD8 BIRC6 NUP205 UBR5 VPS35 PRKDC RPL5	9.37e-06	534	137	11	35032548
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	MYH10 ABL2 CCT3 BMP2K KRT35 PIK3CB PRKDC KRT36	1.13e-05	266	137	8	19380743
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	MYH10 CCT3 MYO1E BMP2K POR NUP205 PRKDC PLEC	1.19e-05	268	137	8	33024031
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 MYO1E KALRN HECTD4 ARFGEF2 DYNC2I1 GAS7 EXTL3 RYR3 FOCAD UBE2O ZNF558 CCDC15 MACF1 CHD6 PRKDC PLEC	1.29e-05	1285	137	17	35914814
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	UBR5 ENAH MACF1 PRKDC PLEC	1.30e-05	76	137	5	27542412
Pubmed	The role and molecular mechanism of metabolic reprogramming of colorectal cancer by UBR5 through PYK2 regulation of OXPHOS expression study.	PTK2B UBR5	1.54e-05	2	137	2	37098808
Pubmed	Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.	AKAP6 ARHGEF10L	1.54e-05	2	137	2	29979793
Pubmed	Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently.	ITGA11 PRKDC	1.54e-05	2	137	2	26990302
Pubmed	CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis.	CUL4A PCID2	1.54e-05	2	137	2	19481525
Pubmed	CUL-4A is critical for early embryonic development.	CUL4A PCID2	1.54e-05	2	137	2	12077329
Pubmed	Enforced expression of CUL-4A interferes with granulocytic differentiation and exit from the cell cycle.	CUL4A PCID2	1.54e-05	2	137	2	12393421
Pubmed	Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis.	CUL4A PCID2	1.54e-05	2	137	2	18339895
Pubmed	Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.	LRRK2 VPS35	1.54e-05	2	137	2	32631998
Pubmed	Cul4A is required for hematopoietic stem-cell engraftment and self-renewal.	CUL4A PCID2	1.54e-05	2	137	2	17616641
Pubmed	Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.	CFHR1 CFHR5	1.54e-05	2	137	2	35392081
Pubmed	VPS35 and retromer dysfunction in Parkinson's disease.	LRRK2 VPS35	1.54e-05	2	137	2	38368930
Pubmed	Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.	CFHR1 CFHR5	1.54e-05	2	137	2	28673452
Pubmed	Intragenic motifs regulate the transcriptional complexity of Pkhd1/PKHD1.	PKHD1 PRKDC	1.54e-05	2	137	2	24984783
Pubmed	A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.	CFHR1 CFHR5	1.54e-05	2	137	2	28729035
Pubmed	What lysosomes actually tell us about Parkinson's disease?	LRRK2 VPS35	1.54e-05	2	137	2	26947123
Pubmed	Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells.	PTPRC PRKDC	1.54e-05	2	137	2	21135032
Pubmed	Defining the membrane proteome of NK cells.	NAA15 NUP107 DOCK10 ARFGEF2 POR CCDC77 BIRC6 ITPR1 NUP205 PTPRC UBR5 PI4KA PRKDC MED17 ACAP2 RPL5	1.55e-05	1168	137	16	19946888
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	ANKFY1 NUP107 CCT3 BIRC6 NUP205 UBE2O UBR5 PI4KA VPS35 KCTD2 PRKDC	1.74e-05	571	137	11	37167062
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYH10 NUP107 CCT3 POR USP46 CCDC77 BIRC6 ITPR1 PTPRC FDFT1 PI4KA SVIL ENAH CDK5RAP2 PIBF1	1.78e-05	1049	137	15	27880917
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	MYH10 NAA15 CCT3 BMP2K NUP205 FDFT1 PI4KA VPS35 MACF1 PRKDC PLEC RPL5	2.50e-05	707	137	12	19738201
Pubmed	A genome-wide search for quantitative trait loci affecting the cortical surface area and thickness of Heschl's gyrus.	KALRN COBLL1 CCDC149 FDFT1	2.52e-05	43	137	4	25130324
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYH10 ANKFY1 CCT3 KALRN HECTD4 CHD8 UBE2O UBR5 PI4KA SVIL ENAH CDK5RAP2 MACF1 UNC79	2.87e-05	963	137	14	28671696
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	AKAP6 ANKFY1 KALRN GAS7 BIRC6 FDFT1 CDK5RAP2 MACF1 PLEC ZNF417	2.95e-05	497	137	10	23414517
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYH10 MYO1E MYO7B PLEC	3.03e-05	45	137	4	22114352
Pubmed	WDFY4 is required for cross-presentation in response to viral and tumor antigens.	MYH10 CCT3 MYO1E ARFGEF2 PLEC ACAP2	3.75e-05	156	137	6	30409884
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ANKFY1 NUP107 CHD8 RFX1 BIRC6 UBR5 CHD6 PLEC CSTPP1	4.44e-05	418	137	9	34709266
Pubmed	Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis.	CUL4A PCID2	4.61e-05	3	137	2	16467204
Pubmed	Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.	PTPRC PRKDC	4.61e-05	3	137	2	29259102
Pubmed	Supervillin binding to myosin II and synergism with anillin are required for cytokinesis.	MYH10 SVIL	4.61e-05	3	137	2	24088567
Pubmed	CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing.	CCNL2 CCNL1	4.61e-05	3	137	2	17261272
Pubmed	Genome-wide analysis of copy-number variation in humans with cleft lip and/or cleft palate identifies COBLL1, RIC1, and ARHGEF38 as clefting genes.	COBLL1 RIC1	4.61e-05	3	137	2	36493769
Pubmed	The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.	CHD8 CHD6	4.61e-05	3	137	2	28533432
Pubmed	Characterization of cyclin L1 as an immobile component of the splicing factor compartment.	CCNL2 CCNL1	4.61e-05	3	137	2	17494991
Pubmed	Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection.	CCNL2 CCNL1	4.61e-05	3	137	2	18216018
Pubmed	Relaxin confers cytotrophoblast protection from hypoxia-reoxygenation injury through the phosphatidylinositol 3-kinase-Akt/protein kinase B cell survival pathway.	PTK2B PIK3CB	4.61e-05	3	137	2	28122716
Pubmed	Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.	ITGA11 PRKDC	4.61e-05	3	137	2	26148229
Pubmed	RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.	LRRK2 VPS35	4.61e-05	3	137	2	23395371
Pubmed	Role and regulation of phosphatidylinositol 3-kinase β in platelet integrin α2β1 signaling.	PTK2B PIK3CB	4.61e-05	3	137	2	22106345
Pubmed	Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation.	LRRK2 VPS35	4.61e-05	3	137	2	38862989
Pubmed	Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties.	PRKDC MX1	4.61e-05	3	137	2	24307589
Pubmed	The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.	LRRK2 VPS35	4.61e-05	3	137	2	29743203
Pubmed	Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity.	LRRK2 VPS35	4.61e-05	3	137	2	33135724
Pubmed	C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.	CFHR1 CFHR5	4.61e-05	3	137	2	23728178
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	MYH10 ANKFY1 NAA15 NUP107 CCT3 NUP205 UBE2O VPS35 PRKDC PLEC RPL5	4.78e-05	638	137	11	33239621
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AKAP6 JADE3 HECTD4 CHD8 SLC7A6 ARHGEF10L NUP205 UBE2O CDK5RAP2 ACAP2	4.98e-05	529	137	10	14621295
Pubmed	Tagging genes with cassette-exchange sites.	NAA15 OTUB1 ARFGEF2 CHD8 BIRC6 ENAH MACF1 PLEC	5.80e-05	335	137	8	15741177
Pubmed	The E3 ubiquitin ligase UBR5 interacts with the H/ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells.	CCNL2 UBR5 CCNL1 PRKDC PCID2	5.93e-05	104	137	5	31365120
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CUL4A PRUNE2 VIPR1 MYH10 SLC38A9 HECTD4 DYNC2I1 MSH5 TMCO4 ZNF587 RIN2 ENAH ARHGEF9 MACF1 CHD6 RIC1 KLHL26	8.16e-05	1489	137	17	28611215
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	NUP107 BMP2K POR CHD8 RFX1 NUP205 RAB18 FDFT1 VPS35 CCNL1 PRKDC PLEC ZNF417 RPL5 PCID2	8.40e-05	1203	137	15	29180619
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	NUP107 CCDC77 UBE2O SVIL TENM1 MACF1 CSTPP1	8.71e-05	263	137	7	34702444
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	CUL4A MYH10 CCT3 VPS35 PLEC PIBF1	8.81e-05	182	137	6	31067453
Pubmed	CDK11(p58) kinase activity is required to protect sister chromatid cohesion at centromeres in mitosis.	CCNL2 CCNL1	9.19e-05	4	137	2	24436071
Pubmed	Specific function of phosphoinositide 3-kinase beta in the control of DNA replication.	PTK2B PIK3CB	9.19e-05	4	137	2	19416922
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR3 ITPR1	9.19e-05	4	137	2	23413940
Pubmed	Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle.	CCNL2 CCNL1	9.19e-05	4	137	2	2217177
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR3 ITPR1	9.19e-05	4	137	2	9607712
Pubmed	Mapping of Abll within a conserved linkage group on distal mouse chromosome 1 syntenic with human chromosome 1 using an interspecific cross.	ABL2 PTPRC	9.19e-05	4	137	2	2567701
Pubmed	Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes.	DNAH10 DNAH9	9.19e-05	4	137	2	11175280
Pubmed	Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.	DNAH9 DNAH11	9.19e-05	4	137	2	36140829
Pubmed	Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate.	LRRK2 PIK3CB	9.19e-05	4	137	2	25854701
Pubmed	Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia.	PTPRC PRKDC	9.19e-05	4	137	2	36848231
Pubmed	Activation of phosphatidylinositol 3-kinase β by the platelet collagen receptors integrin α2β1 and GPVI: The role of Pyk2 and c-Cbl.	PTK2B PIK3CB	9.19e-05	4	137	2	25960397
Pubmed	Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.	LRRK2 VPS35	9.19e-05	4	137	2	27777137
Pubmed	Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway.	CUL4A OTUB1 UBR5	1.00e-04	23	137	3	22038470
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	CCT3 GNE BIRC6 UBR5 CCNL1 PLEC MED17	1.00e-04	269	137	7	29511261
Pubmed	Repression of rRNA transcription by PARIS contributes to Parkinson's disease.	NAA15 NUP107 CCT3 OTUB1 UBR5 PRKDC RPL5	1.07e-04	272	137	7	25315684
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	BIRC6 CDK5RAP2 PRKDC PLEC	1.15e-04	63	137	4	29162697
Pubmed	DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.	MYO1E SVIL PRKDC PLEC	1.15e-04	63	137	4	37052853
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	MYH10 CCT3 MYO1E SVIL MACF1 PLEC	1.15e-04	191	137	6	33762435
Pubmed	AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair.	MXRA5 SFXN5 UBE2O PKHD1 PRKDC	1.21e-04	121	137	5	31900314
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	NAA15 CCT3 MYO1E NUP205 UBE2O FDFT1 MACF1 PRKDC PLEC RPL5 PCID2	1.25e-04	711	137	11	33022573
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	AKAP6 VIPR1 CCT3 RYR3 SVIL PRKDC	1.29e-04	195	137	6	17110338
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ABL2 KALRN PTK2B UBR5 PI4KA ENAH MACF1	1.31e-04	281	137	7	28706196
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	MYH10 PTK2B SVIL ENAH	1.46e-04	67	137	4	29254152
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CUL4A MYH10 NAA15 CCT3 MYO1E BIRC6 TOE1 RAB18 UBE2O UBR5 VPS35 ENAH MACF1 PRKDC PLEC RPL5	1.49e-04	1415	137	16	28515276
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	MYH10 NAA15 CCT3 NUP205 PI4KA VPS35 PRKDC PLEC RPL5	1.51e-04	491	137	9	22623428
Pubmed	Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin.	CCNL2 CCNL1	1.53e-04	5	137	2	11683997
Pubmed	Factor H-related proteins determine complement-activating surfaces.	CFHR1 CFHR5	1.53e-04	5	137	2	25979655
Pubmed	SCFFBXW7 regulates G2-M progression through control of CCNL1 ubiquitination.	CUL4A CCNL1	1.53e-04	5	137	2	36278408
Pubmed	Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance.	CUL4A CCNL2	1.53e-04	5	137	2	25532805
Pubmed	Proteomic and biochemical studies of calcium- and phosphorylation-dependent calmodulin complexes in Mammalian cells.	ITPR1 UBR5	1.53e-04	5	137	2	17696464
Pubmed	CDK11(p58) protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway.	CCNL2 CCNL1	1.53e-04	5	137	2	17516030
GeneFamily	Dyneins, axonemal	DNAH10 DNAH9 DNAH11	9.94e-05	17	98	3	536
GeneFamily	EF-hand domain containing\|Plakins	MACF1 PLEC	7.97e-04	8	98	2	939
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	AKAP6 PRUNE2 MYH10 MYO1E KALRN COBLL1 DOCK10 RYR3 ITPR1 SVIL ENAH MACF1	7.01e-13	188	137	12	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	AKAP6 PRUNE2 MYH10 MYO1E KALRN COBLL1 DOCK10 RYR3 ARHGEF10L ITPR1 ENAH MACF1	7.47e-13	189	137	12	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 DNAH10 KALRN MYO7B NKAIN2 RYR3 PKHD1 TENM1 DNAH9 UNC79 DNAH11	1.34e-11	184	137	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 DNAH10 KALRN MYO7B NKAIN2 RYR3 PKHD1 TENM1 DNAH9 UNC79 DNAH11	1.34e-11	184	137	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 DNAH10 KALRN MYO7B NKAIN2 RYR3 PKHD1 TENM1 DNAH9 UNC79 DNAH11	1.34e-11	184	137	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	AKAP6 PRUNE2 MYH10 MYO1E KALRN COBLL1 ITPR1 ENAH PDE5A	5.73e-09	183	137	9	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	AKAP6 PRUNE2 MYH10 MYO1E KALRN COBLL1 ITPR1 PDE5A	1.03e-07	183	137	8	818fd886e0188091310825f9145fa53328f2c979
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	ANKFY1 DOCK10 SLC7A6 BIRC6 PTPRC ZNF587 MACF1 PRKDC	1.12e-07	185	137	8	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	ANKFY1 DOCK10 SLC7A6 BIRC6 PTPRC ZNF587 MACF1 PRKDC	1.16e-07	186	137	8	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	ANKFY1 DOCK10 ARFGEF2 SLC7A6 BIRC6 PTPRC MACF1 PRKDC	1.43e-07	191	137	8	9454f642c3621370fa23640b631301346b300950
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AMPD3 KALRN ZFP57 DYNC2I1 TEX14 RYR3 KLHL8	8.43e-07	166	137	7	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AMPD3 KALRN ZFP57 DYNC2I1 TEX14 RYR3 KLHL8	8.43e-07	166	137	7	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 DNAH10 RYR3 PKHD1 DNAH9 UNC79 DNAH11	9.51e-07	169	137	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AKAP6 PRUNE2 MYH10 KALRN ARHGEF10L SVIL PDE5A	1.11e-06	173	137	7	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1E BMP2K LRRK2 DOCK10 PTPRC CCNL1 MACF1	1.56e-06	182	137	7	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COBLL1 ZFP57 NPAS3 STK32A GLP1R SVIL	2.37e-06	124	137	6	36dfc702a570e1a1a6dde09f38badf9023ea7287
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 PRUNE2 ITGA11 MYH10 KALRN ARHGEF10L ENAH	2.64e-06	197	137	7	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUP107 CXorf38 COBLL1 HAUS3 UBE2O NEK8	1.19e-05	164	137	6	1d0d88132baaa3154c3e6e4ef0aff795afab08a2
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUP107 CXorf38 COBLL1 HAUS3 UBE2O NEK8	1.19e-05	164	137	6	bd2e10b015d5e6a338675500ec5d81dc39583b3e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHR LRRK2 RYR3 UNC5CL PKHD1 TENM1	1.19e-05	164	137	6	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL19A1 ZFP57 NPAS3 STK32A PDE5A CHD6	1.41e-05	169	137	6	c135d7ae0490d0024e0f4bd8c4ad42f6674a61da
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	AKAP6 PRUNE2 MYH10 KALRN RYR3 PDE5A	1.61e-05	173	137	6	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	facs\|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA11 OTUB1 GAS7 SLC7A6 BIRC6 PLEC	1.71e-05	175	137	6	53e96956019f984decc1c81376ebc88fbf3c4d40
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	AKAP6 PRUNE2 ITGA11 MYH10 KALRN SVIL	2.01e-05	180	137	6	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1E BMP2K LRRK2 PTPRC CCNL1 MACF1	2.20e-05	183	137	6	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1E BMP2K LRRK2 PTPRC CCNL1 MACF1	2.20e-05	183	137	6	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	AKAP6 PRUNE2 MYH10 KALRN ENAH PDE5A	2.49e-05	187	137	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	DOCK10 BIRC6 ITPR1 PTPRC CCNL1 MACF1	2.57e-05	188	137	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 COL19A1 SVIL ENAH PDE5A DNAH11	2.57e-05	188	137	6	879de94924de978478696fc7838e05a4d795b905
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 COL19A1 SVIL ENAH PDE5A DNAH11	2.64e-05	189	137	6	ab7ece0a517499b70b7754720d3e434765363af6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 GNE LRRK2 PIK3CB PKHD1 DNAH11	2.64e-05	189	137	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	MYH10 MXRA5 MYO1E COBLL1 ARHGEF10L PKHD1	2.97e-05	193	137	6	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 RYR3 SVIL ENAH MACF1 PDE5A	2.97e-05	193	137	6	0256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	ITGA11 MYH10 MXRA5 GAS7 ENAH MUSK	3.06e-05	194	137	6	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KALRN DOCK10 GAS7 NKAIN2 ENAH MACF1	3.06e-05	194	137	6	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	ABL2 COL19A1 LRRK2 GAS7 OR2B11 PTK2B	3.06e-05	194	137	6	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KALRN DOCK10 GAS7 NKAIN2 ENAH MACF1	3.15e-05	195	137	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LRRK2 GPAM STK32A UNC5CL CCNL1 PIBF1	3.43e-05	198	137	6	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COBLL1 ZFP57 NPAS3 GLP1R SVIL	7.05e-05	139	137	5	9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KALRN LRRK2 PTPRC CCDC15 PRKDC	1.04e-04	151	137	5	b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 COL19A1 LRRK2 PKHD1 DNAH11	1.11e-04	153	137	5	d6526d17826470534b766df144c74e73eb83fdad
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	AKAP6 KALRN ZFP57 RYR3 ITPR1	1.11e-04	153	137	5	ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKFY1 DNAH10 DOCK10 PTPRC MX1	1.25e-04	157	137	5	ec433d2fe827abdb647be4176c231b7052482b6f
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 JADE3 PIWIL2 PKDREJ CCDC149	1.29e-04	158	137	5	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 JADE3 PIWIL2 PKDREJ CCDC149	1.29e-04	158	137	5	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN DYNC2I1 TEX14 RYR3 KLHL8	1.33e-04	159	137	5	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN DYNC2I1 TEX14 RYR3 KLHL8	1.33e-04	159	137	5	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 MYO7B RYR3 PKHD1 DNAH9	1.37e-04	160	137	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 MYO7B RYR3 PKHD1 DNAH9	1.37e-04	160	137	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	PRUNE2 MYH10 KALRN RYR3 SNX31	1.41e-04	161	137	5	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ZFP57 DOCK10 NPAS3 STK32A PDE5A	1.41e-04	161	137	5	3b5d7a3dab479c6959a428f3954dedd989900276
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 SLC38A9 RYR3 SVIL DNAH11	1.49e-04	163	137	5	1e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibrocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K DOCK10 PTK2B PTPRC MX1	1.58e-04	165	137	5	8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL19A1 BMP2K COBLL1 PIWIL2 ITPR1	1.58e-04	165	137	5	83095377aedf960c05baa523869bdbd2b0a05f2d
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 ZFP57 RADIL LIPH PRKDC	1.62e-04	166	137	5	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 ZFP57 RADIL LIPH PRKDC	1.62e-04	166	137	5	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	ICU-SEP-Lymphocyte-T_NK-dnT\|ICU-SEP / Disease, Lineage and Cell Type	KALRN GPAM UNC5CL CCDC15 BAHCC1	1.62e-04	166	137	5	96d92316cee20b722fe782db9dafcceb8f2c220b
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	COL19A1 COBLL1 ITPR1 PTPRC MACF1	1.76e-04	169	137	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	COVID-19_Mild-PLT_2\|World / Disease Group and Platelet Clusters	AMPD3 ABL2 ZNF558 RIC1 KLHL26	1.76e-04	169	137	5	6abfdc8b437f19c03b408bedc245059d28c6ba6a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E COBLL1 ZFP57 PKDREJ SFXN5	1.76e-04	169	137	5	0332f539a2f7d6dcd081a5d2f567290721f5a329
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 LRRK2 ARHGEF10L PKHD1 DNAH11	1.81e-04	170	137	5	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFHR1 RYR3 SVIL ENAH PDE5A	1.86e-04	171	137	5	fe0665c5ca01b0b2cc8f20d64587f0847c3d215c
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ABL2 DNAH10 CCR9 MUSK	1.87e-04	92	137	4	d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ABL2 DNAH10 CCR9 MUSK	1.87e-04	92	137	4	926e02725a03d8473eda25d4aef63e34a6566224
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	AKAP6 MYH10 KALRN GLP1R ENAH	1.92e-04	172	137	5	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K DOCK10 GAS7 PTPRC MACF1	1.97e-04	173	137	5	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	COVID-19_Mild-PLT_2\|COVID-19_Mild / Disease Group and Platelet Clusters	AMPD3 ABL2 ZNF558 RIC1 KLHL26	1.97e-04	173	137	5	d11705e56b6b21eec963ea224717f27680c781ed
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K DOCK10 GAS7 PTPRC MACF1	1.97e-04	173	137	5	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K DOCK10 GAS7 PTPRC MACF1	1.97e-04	173	137	5	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	Basal_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 NKAIN2 UNC5CL SNX31 ZNF417	2.02e-04	174	137	5	a0060be3940043015dcc49a5157de5541aed24a1
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMP2K HECTD4 GAS7 EXTL3 KLHL26	2.08e-04	175	137	5	1d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BMP2K HECTD4 GAS7 EXTL3 KLHL26	2.08e-04	175	137	5	427a7ee92fe16a90625946492062d37aa0f7235b
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 COL19A1 LRRK2 PIK3CB UNC5CL	2.13e-04	176	137	5	33323c97afe509147956b8df9f92ca6b0537e604
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPAM TOE1 UNC5CL RIN2 UNC79	2.13e-04	176	137	5	30adf8f1638c6244586f8101c2590bb964dfae00
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPAM TOE1 UNC5CL RIN2 UNC79	2.13e-04	176	137	5	23fa02d4c39e0b8faa1658116d50b6233a952ccc
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AMPD3 COL19A1 MYO7B COBLL1 DNAH11	2.25e-04	178	137	5	812e261d9cbdc74fafe3c5c3422151c1cfacb22d
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	COL19A1 MYO1E MYO7B HECTD4 PTPRC	2.25e-04	178	137	5	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COBLL1 LRRK2 TEX14 STK32A UNC5CL	2.30e-04	179	137	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 DYNC2I1 ENAH DNAH9 DNAH11	2.36e-04	180	137	5	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MYO1E COBLL1 DOCK10 SFXN5	2.36e-04	180	137	5	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYH10 CCT3 NKAIN2 RYR3 RPL5	2.43e-04	181	137	5	ee207ea171e2ffc22a7f850be57bb118a87e0f81
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 COBLL1 LRRK2 ARHGEF10L PKHD1	2.43e-04	181	137	5	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	facs-Marrow-T-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CCR9 DOCK10 ARHGEF10L ITPR1	2.43e-04	181	137	5	7286700396676fdc41d9723979b8b408177aceb9
ToppCell	COVID-19-kidney-Stressed_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 MYO7B UNC5CL PKHD1 TENM1	2.43e-04	181	137	5	6980ea624151da32b7f537f263e40fcb87a02e81
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS7 NKAIN2 STK32A TENM1 UNC79	2.49e-04	182	137	5	d568a8aec7e27ce632e248baea2ccd0e8dd255ac
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 MXRA5 MYO1E COBLL1 SFXN5	2.49e-04	182	137	5	f96095b81188b52db8fcfca4837129cfcd9bd7b7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 COBLL1 LRRK2 ARHGEF10L PKHD1	2.49e-04	182	137	5	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS7 NKAIN2 STK32A TENM1 UNC79	2.49e-04	182	137	5	e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 LRRK2 ARHGEF10L PIK3CB PKHD1	2.55e-04	183	137	5	738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 MYO7B UNC5CL PKHD1 TENM1	2.55e-04	183	137	5	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPAS3 USP46 FRMD1 RYR3 DNAH9	2.55e-04	183	137	5	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPAS3 USP46 FRMD1 RYR3 DNAH9	2.55e-04	183	137	5	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 LRRK2 ARHGEF10L PIK3CB PKHD1	2.55e-04	183	137	5	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 MYO7B LRRK2 UNC5CL PKHD1	2.62e-04	184	137	5	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ZNF586 RFX1 VPS35 PDE5A MX1	2.62e-04	184	137	5	9cbfb9f09476b4d09eb8f92c6f21e449dabcfa98
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA11 DNAH10 DYNC2I1 DNAH9 DNAH11	2.62e-04	184	137	5	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK10 BIRC6 PTPRC CCNL1 MACF1	2.62e-04	184	137	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	LRRK2 GAS7 NBPF19 OR2B11 PTK2B	2.62e-04	184	137	5	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COBLL1 LRRK2 RYR3 NBPF19 TENM1	2.62e-04	184	137	5	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GNE LRRK2 PIK3CB PKHD1 DNAH11	2.62e-04	184	137	5	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
Disease	platelet component distribution width	CUL4A PRUNE2 BMP2K KALRN COBLL1 LRRK2 DOCK10 UBE2O PTPRC RIN2 SVIL MACF1 PLEC MUSK	5.92e-06	755	129	14	EFO_0007984
Disease	red blood cell density measurement	DNAH10 BMP2K KALRN COBLL1 ARFGEF2 HDDC2 NUP205 FOCAD PTPRC UBR5 PKHD1 PLEC KLHL8 PIBF1 MUSK	7.41e-06	880	129	15	EFO_0007978
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	ANKFY1 NUP107 MYO1E NUP205	8.75e-06	30	129	4	C1868672
Disease	mean platelet volume	CUL4A NT5DC4 MYO1E KALRN LRRK2 DOCK10 DYNC2I1 PTPRC PIK3CB TRABD PI4KA SVIL PLEC KLHL8 ACAP2 MUSK	1.02e-05	1020	129	16	EFO_0004584
Disease	reticulocyte measurement	CUL4A AMPD3 DNAH10 BMP2K COBLL1 HECTD4 ARFGEF2 BIRC6 UBE2O PTPRC ZNF792 FDFT1 NEK8 PDE5A ACAP2 PCID2	1.51e-05	1053	129	16	EFO_0010700
Disease	CFHR5 DEFICIENCY	CFHR1 CFHR5	1.90e-05	2	129	2	C3553720
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	DNAH10 COBLL1 HECTD4 GPAM FDFT1 MACF1 KLHL8 MUSK	2.21e-05	264	129	8	EFO_0008317, EFO_0020944
Disease	reticulocyte count	AMPD3 DNAH10 BMP2K COBLL1 ZFP57 HECTD4 POR BIRC6 UBE2O PTPRC ZNF792 FDFT1 NEK8 ACAP2 PCID2	5.42e-05	1045	129	15	EFO_0007986
Disease	mean corpuscular hemoglobin concentration	CUL4A CCT3 BMP2K KALRN COBLL1 HECTD4 ARFGEF2 FOCAD PTPRC UBR5 MACF1 PRKDC PIBF1 MED17 MUSK	1.01e-04	1105	129	15	EFO_0004528
Disease	pontocerebellar hypoplasia (implicated_via_orthology)	AMPD3 TOE1	1.88e-04	5	129	2	DOID:0060264 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	NAA15 CHD8 ITPR1 CHD6	2.42e-04	69	129	4	DOID:1682 (implicated_via_orthology)
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	DNAH10 COBLL1 GPAM FDFT1 MACF1 MUSK	2.56e-04	200	129	6	EFO_0004611, EFO_0020945
Disease	procollagen C-endopeptidase enhancer 1 measurement	MUSK DNAH11	2.81e-04	6	129	2	EFO_0801920
Disease	unipolar depression, bipolar disorder, mental or behavioural disorder	AMPD3 NPAS3	2.81e-04	6	129	2	EFO_0000677, EFO_0003761, MONDO_0004985
Disease	platelet crit	MYO1E KALRN SLC38A9 LRRK2 DOCK10 GPAM NUP205 PTPRC TRABD SVIL PDE5A PLEC KLHL8	2.83e-04	952	129	13	EFO_0007985
Disease	CHARGE syndrome (implicated_via_orthology)	CHD8 CHD6	3.93e-04	7	129	2	DOID:0050834 (implicated_via_orthology)
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 FDFT1 TRABD MACF1 MUSK	4.68e-04	224	129	6	EFO_0004530, EFO_0008317
Disease	platelet measurement	NT5DC4 KALRN LRRK2 DOCK10 DYNC2I1 PLEC MUSK	4.87e-04	315	129	7	EFO_0005036
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	AMPD3 DNAH10 COBLL1 GPAM FDFT1 KLHL8 MUSK	5.44e-04	321	129	7	EFO_0004612, EFO_0004639
Disease	lymphocyte count	CALR3 DNAH10 KALRN SLC38A9 COBLL1 HECTD4 DOCK10 ITPR1 FOCAD OR2B11 UBE2O PTPRC FDFT1 KCTD2 PLEC ACAP2	6.68e-04	1464	129	16	EFO_0004587
Disease	C3 glomerulopathy	CFHR1 CFHR5	6.69e-04	9	129	2	C4087273
Disease	venous thromboembolism, response to antineoplastic agent	KALRN PKHD1 RIC1	7.71e-04	41	129	3	EFO_0004286, GO_0097327
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 COBLL1 FDFT1 MUSK	8.16e-04	95	129	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	myeloid white cell count	PRUNE2 AMPD3 DNAH10 MYO1E SLC38A9 HECTD4 GPAM PTK2B UBE2O PTPRC ENAH MUSK	8.56e-04	937	129	12	EFO_0007988
Disease	complement factor H-related protein 3 measurement	AKAP6 CFHR1 KALRN CFHR5 NUP205	9.02e-04	169	129	5	EFO_0600056
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	COBLL1 GPAM MUSK DNAH11	9.52e-04	99	129	4	EFO_0004611, EFO_0007878
Disease	hemopexin measurement	CFHR1 CFHR5	1.02e-03	11	129	2	EFO_0008149
Disease	very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 FDFT1 KLHL8 MUSK DNAH11	1.02e-03	260	129	6	EFO_0008317
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 FDFT1 MUSK	1.23e-03	106	129	4	EFO_0008317, EFO_0008596
Disease	coffee consumption measurement	AKAP6 NPAS3 POR BIRC6 PKHD1	1.25e-03	182	129	5	EFO_0006781
Disease	polyunsaturated fatty acids to total fatty acids percentage	COBLL1 KLHL8 MUSK	1.38e-03	50	129	3	EFO_0022303
Disease	cholesteryl esters to total lipids in IDL percentage	COBLL1 GPAM MACF1	1.38e-03	50	129	3	EFO_0022247
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	DNAH10 COBLL1 BIRC6 FDFT1 MACF1 MUSK	1.38e-03	276	129	6	EFO_0004612, EFO_0020943
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 FDFT1 MUSK	1.41e-03	110	129	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 FDFT1 MUSK	1.41e-03	110	129	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 FDFT1 MUSK	1.41e-03	110	129	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	lean body mass	AMPD3 TRHR SLC38A9 NPAS3 GPAM CCDC149 PLEC	1.43e-03	379	129	7	EFO_0004995
Disease	level of Sphingomyelin (d34:2) in blood serum	MUSK RIC1	1.43e-03	13	129	2	OBA_2045174
Disease	Heschl's gyrus morphology measurement	KALRN COBLL1 CCDC149	1.63e-03	53	129	3	EFO_0005852
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	SFXN5 MUSK	1.67e-03	14	129	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	MYO1E MUSK	1.67e-03	14	129	2	OBA_2045142
Disease	alcohol use disorder (implicated_via_orthology)	VIPR1 RYR3 PIK3CB GLP1R UNC79	1.70e-03	195	129	5	DOID:1574 (implicated_via_orthology)
Disease	omega-6 polyunsaturated fatty acid measurement	COBLL1 OR2B11 FDFT1 MUSK DNAH11	1.78e-03	197	129	5	EFO_0005680
Disease	free cholesterol to total lipids in very large HDL percentage	COBLL1 GPAM MUSK	1.81e-03	55	129	3	EFO_0022288
Disease	immature platelet measurement	KALRN DOCK10 SVIL PLEC	1.88e-03	119	129	4	EFO_0803541
Disease	triglycerides in large VLDL measurement	DNAH10 COBLL1 MUSK	1.91e-03	56	129	3	EFO_0022178
Disease	glycerate measurement	CCR9 RYR3	1.92e-03	15	129	2	EFO_0021029
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	DNAH10 COBLL1 GPAM FDFT1 MUSK	2.16e-03	206	129	5	EFO_0004612, EFO_0020947
Disease	dual specificity mitogen-activated protein kinase kinase 2 measurement	CUL4A PCID2	2.19e-03	16	129	2	EFO_0008112
Disease	Rolandic epilepsy	KALRN RAB18	2.19e-03	16	129	2	Orphanet_1945
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	NEK8 PKHD1	2.19e-03	16	129	2	DOID:0110861 (implicated_via_orthology)
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	AMPD3 COBLL1 GPAM BIRC6 MUSK DNAH11	2.21e-03	303	129	6	EFO_0004612, EFO_0020945
Disease	cholesterol to total lipids in IDL percentage	COBLL1 GPAM MACF1	2.33e-03	60	129	3	EFO_0022233
Disease	free cholesterol to total lipids in medium HDL percentage	COBLL1 GPAM MUSK	2.33e-03	60	129	3	EFO_0022282
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	COBLL1 GPAM MACF1 KLHL8 MUSK DNAH11	2.36e-03	307	129	6	EFO_0004612, EFO_0020946
Disease	free cholesterol in very large VLDL measurement	DNAH10 COBLL1 MUSK	2.44e-03	61	129	3	EFO_0022274
Disease	low density lipoprotein cholesterol measurement, body fat percentage	DNAH10 COBLL1	2.47e-03	17	129	2	EFO_0004611, EFO_0007800
Disease	total lipids in very large VLDL measurement	DNAH10 COBLL1 MUSK	2.56e-03	62	129	3	EFO_0022313
Disease	free cholesterol in very large HDL measurement	COBLL1 GPAM MUSK	2.56e-03	62	129	3	EFO_0022273
Disease	phospholipids in very large VLDL measurement	DNAH10 COBLL1 MUSK	2.56e-03	62	129	3	EFO_0022299
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 FDFT1 MUSK DNAH11	2.60e-03	215	129	5	EFO_0008317, EFO_0008591
Disease	Malignant neoplasm of breast	AKAP6 COL19A1 KALRN ARFGEF2 CFHR5 PKDREJ PTPRC PIK3CB TENM1 MROH7 MACF1 DNAH9	2.68e-03	1074	129	12	C0006142
Disease	sphingosine 1-phosphate measurement	ITPR1 UBE2O	2.77e-03	18	129	2	EFO_0800185
Disease	protein Z-dependent protease inhibitor measurement	CUL4A PCID2	2.77e-03	18	129	2	EFO_0021849
Disease	susceptibility to hepatitis B infection measurement	ARFGEF2 ENAH KCTD2	2.80e-03	64	129	3	EFO_0008405
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 COBLL1 FDFT1 MUSK DNAH11	2.87e-03	220	129	5	EFO_0004529, EFO_0008317
Disease	cholesterol in very large VLDL measurement	DNAH10 COBLL1 MUSK	2.93e-03	65	129	3	EFO_0022230
Disease	total lipids in very large HDL measurement	COBLL1 GPAM MUSK	3.06e-03	66	129	3	EFO_0022312
Disease	phospholipids in very large HDL measurement	COBLL1 GPAM MUSK	3.06e-03	66	129	3	EFO_0022298
Disease	body mass index, high density lipoprotein cholesterol measurement	DNAH10 COBLL1	3.09e-03	19	129	2	EFO_0004340, EFO_0004612
Disease	thrombin activatable fibrinolysis inhibitor activation peptide measurement	DOCK10 ITPR1	3.09e-03	19	129	2	EFO_0008582
Disease	level of Phosphatidylethanolamine (18:0_20:4) in blood serum	MYO1E MUSK	3.09e-03	19	129	2	OBA_2045140
Disease	triglyceride measurement, body mass index	DNAH10 COBLL1	3.09e-03	19	129	2	EFO_0004340, EFO_0004530
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 GPAM FDFT1 MUSK	3.10e-03	224	129	5	EFO_0004574, EFO_0008317
Disease	fatty acid measurement	COBLL1 GAS7 GPAM FDFT1 MACF1 KLHL8 MUSK	3.13e-03	436	129	7	EFO_0005110
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	DNAH10 COBLL1 GPAM FDFT1 MUSK	3.16e-03	225	129	5	EFO_0008317, EFO_0010351
Disease	total lipids in large VLDL	DNAH10 COBLL1 MUSK	3.19e-03	67	129	3	EFO_0022175
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	AMPD3 GPAM MACF1	3.19e-03	67	129	3	EFO_0008595, EFO_0020946
Disease	triglycerides to phosphoglycerides ratio	DNAH10 COBLL1 GPAM	3.33e-03	68	129	3	EFO_0022327
Disease	free cholesterol in large VLDL measurement	DNAH10 COBLL1 MUSK	3.33e-03	68	129	3	EFO_0022265
Disease	lipid measurement, high density lipoprotein cholesterol measurement	AMPD3 DNAH10 COBLL1 GPAM FDFT1 MUSK	3.37e-03	330	129	6	EFO_0004529, EFO_0004612
Disease	Bladder Neoplasm	ANKFY1 OR8S1 POR CHD6	3.38e-03	140	129	4	C0005695
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	DNAH10 COBLL1 FDFT1 MUSK DNAH11	3.40e-03	229	129	5	EFO_0004639, EFO_0008317
Disease	coagulation factor measurement	CFHR5 PCID2	3.42e-03	20	129	2	EFO_0004634
Disease	Severe Combined Immunodeficiency	PTPRC PRKDC	3.42e-03	20	129	2	C0085110
Disease	cholesterol in very large HDL measurement	COBLL1 GPAM MUSK	3.47e-03	69	129	3	EFO_0022229
Disease	Malignant neoplasm of urinary bladder	ANKFY1 OR8S1 POR CHD6	3.47e-03	141	129	4	C0005684
Disease	triglyceride measurement, body fat percentage	DNAH10 COBLL1	3.77e-03	21	129	2	EFO_0004530, EFO_0007800
Disease	intrinsic cardiomyopathy (implicated_via_orthology)	CCT3 RPL5	3.77e-03	21	129	2	DOID:0060036 (implicated_via_orthology)
Disease	triglyceride measurement, phospholipid measurement	DNAH10 COBLL1 GPAM FDFT1	3.93e-03	146	129	4	EFO_0004530, EFO_0004639
Disease	bipolar disorder	AKAP6 CUL4A VIPR1 NPAS3 PDE5A KCTD2 PLEC MUSK	3.94e-03	577	129	8	MONDO_0004985
Disease	phospholipids in large HDL measurement	COBLL1 GPAM MUSK	4.06e-03	73	129	3	EFO_0022190
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	COBLL1 GPAM FDFT1 MACF1 MUSK	4.08e-03	239	129	5	EFO_0008317, EFO_0020945
Disease	Parkinson disease	LRRK2 VPS35	4.14e-03	22	129	2	cv:C0030567
Disease	non-high density lipoprotein cholesterol measurement	DNAH10 COBLL1 ARFGEF2 POR GPAM FDFT1 UNC5CL MUSK DNAH11	4.19e-03	713	129	9	EFO_0005689
Disease	free cholesterol to total lipids in large LDL percentage	COBLL1 GPAM MACF1	4.22e-03	74	129	3	EFO_0022280

Protein segments in the cluster

Peptide	Gene	Start	Entry
KCQVVAREQYEQMAR	BAHCC1	2591	Q9P281
RVFLLNDMLVCANIN	ARHGEF10L	561	Q9HCE6
SQMVRCLDILEDYLI	CHD8	1156	Q9HCK8
MMVALQEDIQCRYNL	BIRC6	1916	Q9NR09
ICMLRVALATVYFQE	CALR3	11	Q96L12
CNREEVTAVVLLYMA	ABL2	376	P42684
IACIFGMQLERDAYV	ARFGEF2	931	Q9Y6D5
NMYQEQCISLEEELA	CCDC77	361	Q9BR77
YVLVCFQECERMNIL	DNAH11	4281	Q96DT5
CLVLEQMARLQQLYL	C8orf58	196	Q8NAV2
LMCELGNDVINRVYE	ACAP2	466	Q15057
VMYLQVLECERNQTL	CCNL1	206	Q9UK58
VLILMEYCRAGQVVN	BMP2K	126	Q9NSY1
RELYAMDVNRESCQI	COBLL1	211	Q53SF7
FEACRLLQQMIDIAI	ARHGEF9	221	O43307
QIRMAFRYETLCNEL	AMPD3	736	Q01432
LEVIQQNCYLMAAED	CDK5RAP2	501	Q96SN8
QNCYLMAAEDLELRS	CDK5RAP2	506	Q96SN8
ALLARAMVQYSCQEL	MROH7	946	Q68CQ1
LETYCTRNDIVNMLV	RAB18	106	Q9NP72
MVLACYNINDRQEEL	RIC1	551	Q4ADV7
YQECLQLADMVSSER	NUP107	871	P57740
SGVIVRLAQCQVYDM	NUP205	1576	Q92621
LLAVMAYDRFVAICN	OR5D14	116	Q8NGL3
MAVLEEVVLYAFQQC	RADIL	556	Q96JH8
ELNASTLMNYCAEII	ANKFY1	176	Q9P2R3
LLVVMAYDRFVAICN	OR52E4	116	Q8NGH9
VIAVMALDRYVAICD	OR1B1	116	Q8NGR6
ADCVLLVVMAYDQFI	OR10V1	111	Q8NGI7
IYVCGDARNMARDVQ	POR	626	P16435
FARMCLDRQYLAINE	ITPR1	741	Q14643
LMVAILYCFVNNEVQ	GLP1R	396	P43220
FLRAACQVMAVLLEE	DYNC2I1	591	Q8WVS4
LDGEMRNAVCIFYLV	FDFT1	61	P37268
QLMYCVRQNREDIVS	EID3	46	Q8N140
ILQVELVARACCEYM	KLHL8	146	Q9P2G9
MQVGFIDAICLQLYE	PDE5A	816	O76074
DIMEALQYLHNCRVA	KALRN	2786	O60229
MQLVCVLERQIFDFL	NKAIN2	16	Q5VXU1
IVEALLGYEMVQVAC	NEK8	436	Q86SG6
MYEQLRDIAIDNICR	PI4KA	561	P42356
VLMSGNVRCYNIVVE	LRRK2	241	Q5S007
NVRCYNIVVEAMKAF	LRRK2	246	Q5S007
LEEMRCQYETLVENN	KRT35	266	Q92764
LCRYDLVLMENVETV	LIPH	426	Q8WWY8
NLRSALTEMCVLYDV	MED17	101	Q9NVC6
LQRCQTYMDIVIVLD	ITGA11	156	Q9UKX5
ECILLVVMAFDRYVA	OR2C1	111	O95371
LEMDVALVQYINQLC	HECTD4	3461	Q9Y4D8
NRNLQTCMEVLEALY	NAA15	796	Q9BXJ9
SDVIMYIQECEGLIR	MACF1	471	Q9UPN3
CIVLAAMALDRYVAI	OR2B11	116	Q5JQS5
FIQRDDLQCFYILNM	NT5DC4	111	Q86YG4
DIDEVQCILANLIYM	PCID2	356	Q5JVF3
VNCLAYDEAIMAQQD	OTUB1	21	Q96FW1
GLCVVRNNEYIFMDL	FRMD1	96	Q8N878
QTLDIMVEDVLCRQY	KLHL26	266	Q53HC5
IDVDALCMENRYLQE	CCDC149	156	Q6ZUS6
ENILVEQLYMCVEFL	DOCK10	1806	Q96BY6
TYEERINLILQMCVE	GNE	441	Q9Y223
LTYMEDAVCQLLENR	CSTPP1	21	Q9H6J7
SQMVRCLDILEDYLI	CHD6	806	Q8TD26
QVISLYMDCNLIARR	COL19A1	181	Q14993
VMYLQVLECERNQHL	CCNL2	201	Q96S94
NADIACLYVILVGEM	EXTL3	231	O43909
CLYAAEGQRLMQERE	CUL4A	241	Q13619
LIMCISVDRYIAIAQ	CCR9	136	P51686
EMARLQLAYICAQHQ	HAUS3	261	Q68CZ6
VSVEVNCRNEYAMIG	CFHR5	291	Q9BXR6
QLDQCEMILQASEYE	HDDC2	141	Q7Z4H3
MVLSELAARLNCAEY	CXorf38	1	Q8TB03
ICQARAAVMVYDDAN	ENAH	6	Q8N8S7
YIVVAFQECGRMNIL	DNAH9	4251	Q9NYC9
CVISREIMENYNIAL	CFHR1	266	Q03591
AENMADLIDGYCRLQ	PTK2B	341	Q14289
YMATICQDLSDVLQI	DNAH10	466	Q8IVF4
QENNVRDLCIAYMLV	SLC38A9	386	Q8NBW4
INIMELAASVCRYDL	JADE3	126	Q92613
AYRCMLQDREDQSIL	MYH10	161	P35580
ALNLLEMIQQECYRD	FOCAD	381	Q5VW36
ILEDMRCQYEALVEN	KRT36	261	O76013
VYRVLQCQEEELTQM	KCTD2	186	Q14681
EIRDQETLLMYQLQC	MSH5	496	O43196
ANNDIFLYEILRSMC	TRIM49	296	P0CI25
YLLQLMAVCLSQDLE	TEX14	306	Q8IWB6
RQIAVYSENMELCSQ	PRUNE2	291	Q8WUY3
NCYLVSLAVADLMVL	TRHR	61	P34981
GARVIYFCLQEMAQE	TMCO4	406	Q5TGY1
EAAIIETNCIYRLMD	SVIL	1556	O95425
FYILEQQCVGLAVDM	NBPF19	1121	A0A087WUL8
YILEQQCVGLAVDMD	NBPF19	1366	A0A087WUL8
FYILEQQCVGLAVDM	NBPF19	2341	A0A087WUL8
YILEQQCVGLAVDMD	NBPF19	2586	A0A087WUL8
FYILEQQCVGLAVDM	NBPF19	3561	A0A087WUL8
LYREHCEAIVDVMVN	RFX1	611	P22670
RNDCVLDVMHAIYQQ	PIWIL2	386	Q8TC59
LAYVVDEGCIIMQER	PKDREJ	1976	Q9NTG1
DDLMRCVDLYNQAQS	GAS7	381	O60861
IMEAIIACSLYAVLN	GPAM	581	Q9HCL2
ICQIAYARIEGDMIV	RPL5	61	P46777
RILQMEEEYIQQLCE	CCT3	266	P49368
QYDNVGRMVICDIRV	TENM1	2126	Q9UKZ4
RVNMDLNIIYCENRI	NPAS3	336	Q8IXF0
YVQCDLTVAMATEQL	PKHD1	1816	P08F94
CLRQMSDEELSQYLL	PIK3CB	626	P42338
FICELVMALDYLQNQ	STK32A	126	Q8WU08
ALINVLLAVNMVFCE	OR8S1	156	Q8NH09
DCRVAVDLLYMQAIQ	SNX31	216	Q8N9S9
CYLEAQRDAVEQMSL	AKAP6	916	Q13023
QECYAAEQRILRMNF	CCDC15	811	Q0P6D6
ILSERQDMYQCLVEG	ZNF511	136	Q8NB15
VLTYVIAQCDMLELD	RIN2	701	Q8WYP3
LLNEAQRCLYRDVML	ZNF586	31	Q9NXT0
ARLQEECDYVQMIEV	VIPR1	31	P32241
DCLDASQRVLYQDVM	ZFP57	31	Q9NU63
MLALVLNCIDRLNVY	RYR3	481	Q15413
DVVVVELCQYRVSML	TRABD	101	Q9H4I3
ALAQEYLMECIIQVF	VPS35	256	Q96QK1
TLYRDVMLENCRNLA	ZNF558	66	Q96NG5
QRCLYRDVMLENLAL	ZNF587	36	Q96SQ5
MCQDLRVLNAVRDYH	VPS16	421	Q9H269
EYLNRQNMELSVRCA	PIBF1	321	Q8WXW3
QRCLYRDVMLENLAL	ZNF417	36	Q8TAU3
NSRCYNEMALIRVVQ	UBE2O	1096	Q9C0C9
TVMERLDCASAIQNY	UNC5CL	476	Q8IV45
NTEENLTYLQLMERC	PLEC	4231	Q15149
VLCRVEGMTELYFQL	PRKDC	2401	P78527
LFNCTMALIYLIVED	SLC7A6	371	Q92536
NLDRMYDLVAVVVHC	USP46	291	P62068
AEQLYRLEMEFQRCQ	VAX2	111	Q9UIW0
LDEAQRLLYCDVMLE	ZNF792	31	Q3KQV3
CRDIANMIILLVYVR	ZBED9	906	Q6R2W3
ANICNVVLMRYGELE	SFXN5	211	Q8TD22
YRDVMLENCRNLASL	ZNF557	61	Q8N988
QRCLMVQVEAQYILI	PTPRC	891	P08575
YLAQVFNLTLLCMEE	TOE1	116	Q96GM8
EACRQYLMNLEQAVV	UBR5	886	O95071
AAMECVRQYINEVLD	UNC79	2316	Q9P2D8
EYVMQENCGIVVSLR	ZNF641	136	Q96N77
IRLHFQMEQIVYCQD	MX1	521	P20591
YRNMIIDRENQCVII	MYO1E	96	Q12965
GLYQCIAQVRDEMDR	MXRA5	551	Q9NR99
EQLCIARQVAAGMAY	MUSK	701	O15146
IACQIFVAILRYMGD	MYO7B	1666	Q6PIF6